Drugs / IFN-α
last change Dec 2015 re-read 2 minutes ago

IFN-α

Developed for
renal cell carcinoma

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00862303 Comparator Mar 2009 → Jun 2015 renal cell carcinoma Fuzhou General Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as IFN-α ClinicalTrials.gov intervention name — accepted as the source's own label NCT00862303